세계의 주입용 시멘트 시장 : 유형별, 용도별, 최종 사용자별-기회 분석 및 산업 예측(2021-2031년)

The global injectable cement market was valued at $1,321.7 million in 2021, and is projected to reach $2,297.0 million by 2031, registering a CAGR of 5.7% from 2022 to 2031. Injectable cement is the synthetic materials used for filling spaces between the prosthesis and bone and provides elasticity. It is used as an adhesive in hip replacement surgery to keep implant in place. It is also used to provide strength for bone stability. Injectable cement is biocompatible and osteoconductive synthetic materials. There are different types of bone cement that are classified on the basis of viscosity, such as low viscosity cement, medium viscosity cement, and highly viscous cement. The viscosity of bone cement affects its properties, including handling time, fixing quality, bone penetration, and stability. Currently available injectable cement includes, calcium sulfate cement and polymethylmethacrylate (PMMA).

The injectable cement market growth is driven by rise in geriatric population, increase in accidental cases, and surge in surgeries performed for hip replacement. For instance, according to the National Highway Traffic Safety Administration (NHTSA), a noticeable increase of 10.5% fatalities was reported in 2021 in the U.S. Furthermore, according to Organisation for Economic Co-operation and Development (OCED) library, in 2019, Germany, Austria, Finland, and Switzerland were among the countries with highest rates for hip and knee replacement. In addition, as per the same source, hip replacement rates increased by 22% between 2009 and 2019 in OECD countries. Moreover, rise in demand for injectable cement drives the growth of the market. In addition, increase in use of injectable cement in the dentistry sector is anticipated to contribute toward the growth of the market. Furthermore, rise in prevalence of bone diseases leads to increase in the number of orthopedic surgeries, which further fosters the market growth.

Moreover, increase in prevalence of bone diseases, such as bone infection, bone tumor, and osteoporosis, leads to increase in the number of orthopedic surgeries, which further fosters the market growth.

However, the high cost associated with surgery and shortage of skilled surgeons hinder the growth of the market. For instance, the cost of total knee replacement surgery without insurance is about $19,995 in the U.S. Moreover, clinical barriers of injectable cement and low penetration act as a major restraint of the global injectable cement market. On the other side, increase in healthcare expenditure and increase in the number of specialized hospitals in countries, such as China and India are expected to create opportunities for the growth of the market.

The injectable cement market is segmented into type, application, end user, and region. By type, the market is segregated into low viscosity cement, medium viscosity cement, and high viscosity cement. On the basis of application, the market is categorized into spine fusion, bone fracture, and others. The others segment includes, craniomaxillofacial and dental bone grafting. Depending on end user, the market is fragmented into hospital, clinics, and others. The others segment includes, research centers and spine centers. Region-wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA).

Major key players that operate in the global injectable cement market are Arthrex Inc., B. Braun Melsungen AG, Cook Medical, Enovis, Johnson and Johnson    , Medacta International SA, Medtronic plc, Smith and Nephew, Stryker Corporation, and Teknimed.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the injectable cement market analysis from 2021 to 2031 to identify the prevailing injectable cement market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the injectable cement market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global injectable cement market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

• High Viscosity Cement
• Low Viscosity Cement
• Medium Viscosity Cement

By Application

• Spine Fusion
• Bone fracture
• Others

By End User

• Hospital
• Clinics
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
• Key Market Players
  • Arthrex
  • cook medical
  • Enovis (DJO Global, Inc.)
  • johnson and johnson md&d
  • Medacta International SA
  • smith and nephew
  • Stryker Corporation
  • B. Braun Melsungen AG
  • Medtronic plc
  • Teknimed

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

• 1.1.Report description
• 1.2.Key market segments
• 1.3.Key benefits to the stakeholders
• 1.4.Research Methodology
  • 1.4.1.Secondary research
  • 1.4.2.Primary research
  • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

• 2.1.Key findings of the study
• 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

• 3.1.Market definition and scope
• 3.2.Key findings
  • 3.2.1.Top investment pockets
• 3.3.Porter's five forces analysis
• 3.4.Top player positioning
• 3.5.Market dynamics
  • 3.5.1.Drivers
  • 3.5.2.Restraints
  • 3.5.3.Opportunities
• 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: INJECTABLE CEMENT MARKET, BY TYPE

• 4.1 Overview
  • 4.1.1 Market size and forecast
• 4.2 Low Viscosity Cement
  • 4.2.1 Key market trends, growth factors and opportunities
  • 4.2.2 Market size and forecast, by region
  • 4.2.3 Market share analysis by country
• 4.3 Medium Viscosity Cement
  • 4.3.1 Key market trends, growth factors and opportunities
  • 4.3.2 Market size and forecast, by region
  • 4.3.3 Market share analysis by country
• 4.4 High Viscosity Cement
  • 4.4.1 Key market trends, growth factors and opportunities
  • 4.4.2 Market size and forecast, by region
  • 4.4.3 Market share analysis by country

CHAPTER 5: INJECTABLE CEMENT MARKET, BY APPLICATION

• 5.1 Overview
  • 5.1.1 Market size and forecast
• 5.2 Spine Fusion
  • 5.2.1 Key market trends, growth factors and opportunities
  • 5.2.2 Market size and forecast, by region
  • 5.2.3 Market share analysis by country
• 5.3 Bone fracture
  • 5.3.1 Key market trends, growth factors and opportunities
  • 5.3.2 Market size and forecast, by region
  • 5.3.3 Market share analysis by country
• 5.4 Others
  • 5.4.1 Key market trends, growth factors and opportunities
  • 5.4.2 Market size and forecast, by region
  • 5.4.3 Market share analysis by country

CHAPTER 6: INJECTABLE CEMENT MARKET, BY END USER

• 6.1 Overview
  • 6.1.1 Market size and forecast
• 6.2 Hospital
  • 6.2.1 Key market trends, growth factors and opportunities
  • 6.2.2 Market size and forecast, by region
  • 6.2.3 Market share analysis by country
• 6.3 Clinics
  • 6.3.1 Key market trends, growth factors and opportunities
  • 6.3.2 Market size and forecast, by region
  • 6.3.3 Market share analysis by country
• 6.4 Others
  • 6.4.1 Key market trends, growth factors and opportunities
  • 6.4.2 Market size and forecast, by region
  • 6.4.3 Market share analysis by country

CHAPTER 7: INJECTABLE CEMENT MARKET, BY REGION

• 7.1 Overview
  • 7.1.1 Market size and forecast
• 7.2 North America
  • 7.2.1 Key trends and opportunities
  • 7.2.2 North America Market size and forecast, by Type
  • 7.2.3 North America Market size and forecast, by Application
  • 7.2.4 North America Market size and forecast, by End User
  • 7.2.5 North America Market size and forecast, by country
    • 7.2.5.1 U.S.
    • 7.2.5.1.1 Key market trends, growth factors and opportunities
    • 7.2.5.1.2 Market size and forecast, by Type
    • 7.2.5.1.3 Market size and forecast, by Application
    • 7.2.5.1.4 Market size and forecast, by End User
    • 7.2.5.2 Canada
    • 7.2.5.2.1 Key market trends, growth factors and opportunities
    • 7.2.5.2.2 Market size and forecast, by Type
    • 7.2.5.2.3 Market size and forecast, by Application
    • 7.2.5.2.4 Market size and forecast, by End User
    • 7.2.5.3 Mexico
    • 7.2.5.3.1 Key market trends, growth factors and opportunities
    • 7.2.5.3.2 Market size and forecast, by Type
    • 7.2.5.3.3 Market size and forecast, by Application
    • 7.2.5.3.4 Market size and forecast, by End User
• 7.3 Europe
  • 7.3.1 Key trends and opportunities
  • 7.3.2 Europe Market size and forecast, by Type
  • 7.3.3 Europe Market size and forecast, by Application
  • 7.3.4 Europe Market size and forecast, by End User
  • 7.3.5 Europe Market size and forecast, by country
    • 7.3.5.1 Germany
    • 7.3.5.1.1 Key market trends, growth factors and opportunities
    • 7.3.5.1.2 Market size and forecast, by Type
    • 7.3.5.1.3 Market size and forecast, by Application
    • 7.3.5.1.4 Market size and forecast, by End User
    • 7.3.5.2 France
    • 7.3.5.2.1 Key market trends, growth factors and opportunities
    • 7.3.5.2.2 Market size and forecast, by Type
    • 7.3.5.2.3 Market size and forecast, by Application
    • 7.3.5.2.4 Market size and forecast, by End User
    • 7.3.5.3 UK
    • 7.3.5.3.1 Key market trends, growth factors and opportunities
    • 7.3.5.3.2 Market size and forecast, by Type
    • 7.3.5.3.3 Market size and forecast, by Application
    • 7.3.5.3.4 Market size and forecast, by End User
    • 7.3.5.4 Italy
    • 7.3.5.4.1 Key market trends, growth factors and opportunities
    • 7.3.5.4.2 Market size and forecast, by Type
    • 7.3.5.4.3 Market size and forecast, by Application
    • 7.3.5.4.4 Market size and forecast, by End User
    • 7.3.5.5 Spain
    • 7.3.5.5.1 Key market trends, growth factors and opportunities
    • 7.3.5.5.2 Market size and forecast, by Type
    • 7.3.5.5.3 Market size and forecast, by Application
    • 7.3.5.5.4 Market size and forecast, by End User
    • 7.3.5.6 Rest of Europe
    • 7.3.5.6.1 Key market trends, growth factors and opportunities
    • 7.3.5.6.2 Market size and forecast, by Type
    • 7.3.5.6.3 Market size and forecast, by Application
    • 7.3.5.6.4 Market size and forecast, by End User
• 7.4 Asia-Pacific
  • 7.4.1 Key trends and opportunities
  • 7.4.2 Asia-Pacific Market size and forecast, by Type
  • 7.4.3 Asia-Pacific Market size and forecast, by Application
  • 7.4.4 Asia-Pacific Market size and forecast, by End User
  • 7.4.5 Asia-Pacific Market size and forecast, by country
    • 7.4.5.1 China
    • 7.4.5.1.1 Key market trends, growth factors and opportunities
    • 7.4.5.1.2 Market size and forecast, by Type
    • 7.4.5.1.3 Market size and forecast, by Application
    • 7.4.5.1.4 Market size and forecast, by End User
    • 7.4.5.2 Japan
    • 7.4.5.2.1 Key market trends, growth factors and opportunities
    • 7.4.5.2.2 Market size and forecast, by Type
    • 7.4.5.2.3 Market size and forecast, by Application
    • 7.4.5.2.4 Market size and forecast, by End User
    • 7.4.5.3 India
    • 7.4.5.3.1 Key market trends, growth factors and opportunities
    • 7.4.5.3.2 Market size and forecast, by Type
    • 7.4.5.3.3 Market size and forecast, by Application
    • 7.4.5.3.4 Market size and forecast, by End User
    • 7.4.5.4 Australia
    • 7.4.5.4.1 Key market trends, growth factors and opportunities
    • 7.4.5.4.2 Market size and forecast, by Type
    • 7.4.5.4.3 Market size and forecast, by Application
    • 7.4.5.4.4 Market size and forecast, by End User
    • 7.4.5.5 South Korea
    • 7.4.5.5.1 Key market trends, growth factors and opportunities
    • 7.4.5.5.2 Market size and forecast, by Type
    • 7.4.5.5.3 Market size and forecast, by Application
    • 7.4.5.5.4 Market size and forecast, by End User
    • 7.4.5.6 Rest of Asia-Pacific
    • 7.4.5.6.1 Key market trends, growth factors and opportunities
    • 7.4.5.6.2 Market size and forecast, by Type
    • 7.4.5.6.3 Market size and forecast, by Application
    • 7.4.5.6.4 Market size and forecast, by End User
• 7.5 LAMEA
  • 7.5.1 Key trends and opportunities
  • 7.5.2 LAMEA Market size and forecast, by Type
  • 7.5.3 LAMEA Market size and forecast, by Application
  • 7.5.4 LAMEA Market size and forecast, by End User
  • 7.5.5 LAMEA Market size and forecast, by country
    • 7.5.5.1 Brazil
    • 7.5.5.1.1 Key market trends, growth factors and opportunities
    • 7.5.5.1.2 Market size and forecast, by Type
    • 7.5.5.1.3 Market size and forecast, by Application
    • 7.5.5.1.4 Market size and forecast, by End User
    • 7.5.5.2 Saudi Arabia
    • 7.5.5.2.1 Key market trends, growth factors and opportunities
    • 7.5.5.2.2 Market size and forecast, by Type
    • 7.5.5.2.3 Market size and forecast, by Application
    • 7.5.5.2.4 Market size and forecast, by End User
    • 7.5.5.3 South Africa
    • 7.5.5.3.1 Key market trends, growth factors and opportunities
    • 7.5.5.3.2 Market size and forecast, by Type
    • 7.5.5.3.3 Market size and forecast, by Application
    • 7.5.5.3.4 Market size and forecast, by End User
    • 7.5.5.4 Rest of LAMEA
    • 7.5.5.4.1 Key market trends, growth factors and opportunities
    • 7.5.5.4.2 Market size and forecast, by Type
    • 7.5.5.4.3 Market size and forecast, by Application
    • 7.5.5.4.4 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

• 8.1. Introduction
• 8.2. Top winning strategies
• 8.3. Product Mapping of Top 10 Player
• 8.4. Competitive Dashboard
• 8.5. Competitive Heatmap
• 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

• 9.1 Arthrex
  • 9.1.1 Company overview
  • 9.1.2 Company snapshot
  • 9.1.3 Operating business segments
  • 9.1.4 Product portfolio
  • 9.1.5 Business performance
  • 9.1.6 Key strategic moves and developments
• 9.2 cook medical
  • 9.2.1 Company overview
  • 9.2.2 Company snapshot
  • 9.2.3 Operating business segments
  • 9.2.4 Product portfolio
  • 9.2.5 Business performance
  • 9.2.6 Key strategic moves and developments
• 9.3 Enovis (DJO Global, Inc.)
  • 9.3.1 Company overview
  • 9.3.2 Company snapshot
  • 9.3.3 Operating business segments
  • 9.3.4 Product portfolio
  • 9.3.5 Business performance
  • 9.3.6 Key strategic moves and developments
• 9.4 johnson and johnson md&d
  • 9.4.1 Company overview
  • 9.4.2 Company snapshot
  • 9.4.3 Operating business segments
  • 9.4.4 Product portfolio
  • 9.4.5 Business performance
  • 9.4.6 Key strategic moves and developments
• 9.5 Medacta International SA
  • 9.5.1 Company overview
  • 9.5.2 Company snapshot
  • 9.5.3 Operating business segments
  • 9.5.4 Product portfolio
  • 9.5.5 Business performance
  • 9.5.6 Key strategic moves and developments
• 9.6 smith and nephew
  • 9.6.1 Company overview
  • 9.6.2 Company snapshot
  • 9.6.3 Operating business segments
  • 9.6.4 Product portfolio
  • 9.6.5 Business performance
  • 9.6.6 Key strategic moves and developments
• 9.7 Stryker Corporation
  • 9.7.1 Company overview
  • 9.7.2 Company snapshot
  • 9.7.3 Operating business segments
  • 9.7.4 Product portfolio
  • 9.7.5 Business performance
  • 9.7.6 Key strategic moves and developments
• 9.8 B. Braun Melsungen AG
  • 9.8.1 Company overview
  • 9.8.2 Company snapshot
  • 9.8.3 Operating business segments
  • 9.8.4 Product portfolio
  • 9.8.5 Business performance
  • 9.8.6 Key strategic moves and developments
• 9.9 Medtronic plc
  • 9.9.1 Company overview
  • 9.9.2 Company snapshot
  • 9.9.3 Operating business segments
  • 9.9.4 Product portfolio
  • 9.9.5 Business performance
  • 9.9.6 Key strategic moves and developments
• 9.10 Teknimed
  • 9.10.1 Company overview
  • 9.10.2 Company snapshot
  • 9.10.3 Operating business segments
  • 9.10.4 Product portfolio
  • 9.10.5 Business performance
  • 9.10.6 Key strategic moves and developments